Abstracts tagged "sarcoidosis"

Abstract Number: 2099 • 2017 ACR/ARHP Annual Meeting
Elderly – Onset Sarcoidosis: a Single Center Comparative Study
Senol Kobak¹, Fidan Yildiz², Huseyin Semiz³ and Mehmet Orman⁴, ¹Rheumatology, Istinye University Faculty of Medicine, Istanbul, Turkey, ²Chest Diseases, Medicalpark Hospital, İzmir, Turkey, ³Internal Medicine, Ege University Faculty of Medicine, İzmir, Turkey, ⁴Statistics, Ege University Faculty of Medicine, İzmir, Turkey
Background/Purpose: Sarcoidosis is a chronic granulomatous inflamatory disease characterized with non-caseified granuloma formation. It is rarely affects patients older than 65 years old..The purpose of…
Abstract Number: 1333 • 2016 ACR/ARHP Annual Meeting
Relevance of Granulomatous Presentation for the Diagnosis and Outcome of Uveitis: Retrospective Case-Control Study of 251 Patients
Jérôme Hadjadj¹, Thibault Chapron², Manal Assala¹, Sawsen Salah², Bertrand Dunogue¹, Matthieu Groh³, Philippe Blanche¹, Luc Mouthon⁴, Dominique Monnet², Claire Le Jeunne⁴, Antoine Brezin² and Benjamin Terrier³, ¹Internal Medicine, Cochin Hospital, Paris, France, ²Ophtalmology, Cochin Hospital, Paris, France, ³National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, ⁴Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, Paris, France
Background/Purpose: Findings of ophthalmologic examination can guide the diagnostic management of uveitis. Granulomatous presentation is commonly associated with peculiar causes, including infections, eye-restricted diseases, or…
Abstract Number: 1395 • 2015 ACR/ARHP Annual Meeting
Prevalence and Significance of MEFV GENE Mutations in Patients with Sarcoidosis
Senol Kobak¹, Fidan Sever², Ozlem Goksel³, Tuncay Goksel³, Mehmet Orman⁴ and Afig Berdeli⁵, ¹Rheumatology, Sifa University Faculty of Medicine, 35100, Turkey, ²Chest Disease, Sifa University, Izmir, Turkey, ³Chest Disease, Ege University, Izmir, Turkey, ⁴Ege University Department of Statistic, Associated Professor, Izmir, Turkey, ⁵Genetics and Molecular Medicine, Ege University, Izmir, Turkey
Background/Purpose: Sarcoidosis is a chronic granulomatous disease. Pyrin, is encoded by the MEFV gene and has anti-inflammatory effects in the inflammasoma regulation. MEFV gene mutations…
Abstract Number: 1247 • 2014 ACR/ARHP Annual Meeting
The Prevalence of Sacroiliitis and Spondyloarthritis in Patients with Sarcoidosis
Senol Kobak¹, Fidan Sever², Ozlem Ince³ and Mehmet Orman⁴, ¹Rheumatology, SIFA UNIVERSITY, Izmir, Turkey, ²Chest Disease, Sifa University, Izmir, Turkey, ³Radiology, Sifa University, Izmir, Turkey, ⁴Ege University Department of Statistic, Associated Professor, Izmir, Turkey
Background/Purpose: Sarcoidosis is a chronic granulomatous disease, which can involve different organs and systems. Coexistence of sarcoidosis and spondyloarthritis has been reported in numerous case…
Abstract Number: 2014 • 2013 ACR/ARHP Annual Meeting
Cigarette Smoking and Male Sex Are Independent Risk Factors For Ocular Sarcoidosis
Adam Janot¹, Dörte Huscher², McCall Walker³, Harmanjot K. Grewal⁴, Mary Yu¹, Matthew R. Lammi^5,6 and Lesley Ann Saketkoo^7,8, ¹Internal Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, ²German Rheumatism Research Centre and Charité University Medicine, Berlin, Germany, ³LSUHSC School of Medicine, New Orleans, LA, ⁴Rheumatology, Lousiana State University Health Sciences Center, New Orleans, LA, ⁵Section of Pulmonary and Critical Care Medicine, LSU Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA, ⁶Louisiana State University Health Sciences Center, Pulmonary and Critical Medicine, New Orleans, LA, ⁷LSU Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA, ⁸Scleroderma and Sarcoidosis Patient Care and Research Center, Rheumatology and Pulmonary Medicine, Louisiana State University Health Sciences Center, New Orleans, LA
Background/Purpose: Sarcoidosis is a multi-organ system granulomatous disease of unknown origin with an incidence of 1-40/100,000. Though pulmonary manifestations are predominant, ocular morbidity is characteristic. …

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].